Ningbo Menovo Pharmaceutical Co., Ltd.

SSE:603538.SS

15.24 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011
Revenue 1,372.8551,216.4991,456.9821,258.1481,193.6981,180.205848.962605.321578.088597.166636.305501.727486.647490.243
Cost of Revenue 925.127873.793872.795788.928758.573727.629572.499399.065361.51400.47426.153329.113326.233331.588
Gross Profit 447.728342.706584.187469.22435.125452.576276.463206.255216.578196.697210.152172.615160.414158.655
Gross Profit Ratio 0.3260.2820.4010.3730.3650.3830.3260.3410.3750.3290.330.3440.330.324
Reseach & Development Expenses 99.65295.29798.15588.31362.0552.9639.20832.02429.07838.12230.55322.60525.9840
General & Administrative Expenses 54.98555.86576.21452.57549.67659.15533.1725.45817.79415.12917.77975.46769.68960.998
Selling & Marketing Expenses 42.53233.01550.62429.2914.3421.33118.87517.312.95512.95513.4449.3028.6078.923
SG&A 97.517220.096126.83881.86564.01680.48652.04542.75830.74928.08331.22284.76978.29669.921
Other Expenses 157.9658.565116.378110.818109.909102.789-5.7980.4911.51510.262.9115.4352.2142.037
Operating Expenses 355.134323.958341.371280.996235.976236.235171.249131.607117.56119.557108.99387.80380.07471.445
Operating Income 92.59418.748405.323187.906215.54189.734112.55763.88198.45491.50491.60984.80775.18992.185
Operating Income Ratio 0.0670.0150.2780.1490.1810.1610.1330.1060.170.1530.1440.1690.1550.188
Total Other Income Expenses Net -5.63-10.79-21.162-7.614-2.352-2.487-5.7980.494.669.5452.5775.126-1.8291.348
Income Before Tax 86.9647.958384.161180.292214.663187.247106.75964.371105.172101.04994.18689.93377.19893.533
Income Before Tax Ratio 0.0630.0070.2640.1430.180.1590.1260.1060.1820.1690.1480.1790.1590.191
Income Tax Expense 10.915-8.22516.54722.22241.60726.4471.69714.41820.04919.27615.69516.26912.8414.818
Net Income 66.80711.586338.856142.526155.963150.90596.34944.67778.84377.0272.7369.00560.6169.335
Net Income Ratio 0.0490.010.2330.1130.1310.1280.1130.0740.1360.1290.1140.1380.1250.141
EPS 0.320.051.610.690.760.750.480.240.520.510.480.460.40.64
EPS Diluted 0.320.051.490.660.760.730.470.240.520.510.480.460.40.64
EBITDA 269.12155.451498.482301.579321.396275.055158.393101.17116.145111.398128.20484.81287.42482.816
EBITDA Ratio 0.1960.1280.3420.240.2690.2330.1870.1670.2010.1870.2010.1690.180.169